Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (7)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Dumortier, H.
Right arrow Articles by Muller, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dumortier, H.
Right arrow Articles by Muller, S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

International Immunology, Vol. 11, No. 2, 249-257, February 1999
© 1999 Japanese Society for Immunology

MHC class II gene associations with autoantibodies to U1A and SmD1 proteins

Hélène Dumortier, Michel Abbal1, Marylise Fort1, Jean-Paul Briand, Alain Cantagrel2 and Sylviane Muller

Institut de Biologie Moléculaire et Cellulaire, CNRS UPR 9021, Strasbourg, France
1 Service de Rhumatologie and
2 Laboratoire d'Immunologie, CHU Rangueil, Toulouse, France

Correspondence to: S. Muller, UPR 9021 CNRS, Institut de Biologie Moléculaire et Cellulaire, 15, rue Descartes, 67084 Strasbourg, France

Autoantibodies against U small nuclear ribonucleoproteins (snRNP) are frequently present in the serum of patients with systemic rheumatic diseases, and have been reported to be associated with HLA-DR and -DQ genes. To better define the role of HLA genes in the production of such antibodies, we studied immunogenetic associations with autoantibodies reacting with U1 RNP, U1A and SmD1 proteins, and synthetic peptides containing immunodominant linear epitopes of these proteins. Only two out of the 15 overlapping peptides of U1A (i.e. peptides 35–58 and 257–282) and three of 11 peptides of SmD1 (i.e. peptides 1–20, 44–67 and 97–119) were significantly recognized by patients' sera selected on the basis of their antibody positivity with RNP in immunodiffusion. The distribution of DRB1, DQB1 and DPB1 alleles among the anti-RNP antibody-positive patients (n = 28) and healthy control subjects was similar. Antibodies against U1A (tested in Western immunoblotting with HeLa cell extracts) were positively associated to DRB1*06 allele; antibodies reacting with SmD1 peptide 44–67 were negatively associated to DRB1*02 and DQB1*0602 alleles. No association was found between DPB1 alleles and antibodies reacting with U1A and SmD1 antigens. This first study reporting an association between autoantibodies reacting with U1A and SmD1 proteins (and peptides of these proteins), and immunogenetic markers suggest that the production of antibody subsets directed against different components (or regions of these proteins) bound to the same snRNP particle is associated with distinct MHC class II alleles.

Keywords: autoantibody, MHC class II, ribonucleoprotein, SmD1, U1A

Transmitting editor: J.-F. Bach


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
H. Dumortier, F. Monneaux, B. Jahn-Schmid, J.-P. Briand, K. Skriner, P. L. Cohen, J. S. Smolen, G. Steiner, and S. Muller
B and T Cell Responses to the Spliceosomal Heterogeneous Nuclear Ribonucleoproteins A2 and B1 in Normal and Lupus Mice
J. Immunol., August 15, 2000; 165(4): 2297 - 2305.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Decker, D. Isenberg, and S. Muller
Inhibition of Caspase-3-mediated Poly(ADP-ribose) Polymerase (PARP) Apoptotic Cleavage by Human PARP Autoantibodies and Effect on Cells Undergoing Apoptosis
J. Biol. Chem., March 17, 2000; 275(12): 9043 - 9046.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.